106 related articles for article (PubMed ID: 30063472)
21. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity.
Druzhkova I; Ignatova N; Prodanets N; Kiselev N; Zhukov I; Shirmanova M; Zagainov V; Zagaynova E
Clin Colorectal Cancer; 2019 Mar; 18(1):e74-e86. PubMed ID: 30415989
[TBL] [Abstract][Full Text] [Related]
22. Antagonist effect of pseudohypericin at CRF1 receptors.
Simmen U; Bobirnac I; Ullmer C; Lübbert H; Berger Büter K; Schaffner W; Schoeffter P
Eur J Pharmacol; 2003 Jan; 458(3):251-6. PubMed ID: 12504780
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic insights into the antileukemic activity of hyperforin.
Billard C; Merhi F; Bauvois B
Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
[TBL] [Abstract][Full Text] [Related]
24. Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse.
Bray BJ; Brennan NJ; Perry NB; Menkes DB; Rosengren RJ
Life Sci; 2002 Feb; 70(11):1325-35. PubMed ID: 11883710
[TBL] [Abstract][Full Text] [Related]
25. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
26. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
Bauer S; Störmer E; Graubaum HJ; Roots I
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):29-35. PubMed ID: 11817306
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry.
Riedel KD; Rieger K; Martin-Facklam M; Mikus G; Haefeli WE; Burhenne J
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):27-33. PubMed ID: 15556512
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
Kleban J; Mikes J; Horváth V; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
J Photochem Photobiol B; 2008 Nov; 93(2):108-18. PubMed ID: 18771933
[TBL] [Abstract][Full Text] [Related]
29. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA
J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
32. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
[TBL] [Abstract][Full Text] [Related]
33. Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin.
Mikes J; Kleban J; Sacková V; Horváth V; Jamborová E; Vaculová A; Kozubík A; Hofmanová J; Fedorocko P
Photochem Photobiol Sci; 2007 Jul; 6(7):758-66. PubMed ID: 17609769
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Schellenberg R; Sauer S; Dimpfel W
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():44-53. PubMed ID: 9684947
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial activity of hyperforin from St John's wort.
Fiebich BL; Heinrich M; Langosch JM; Kammerer N; Lieb K
Lancet; 1999 Aug; 354(9180):777. PubMed ID: 10475222
[No Abstract] [Full Text] [Related]
36. Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.
Rakitina TV; Vasilevskaya IA; O'Dwyer PJ
Cancer Res; 2003 Dec; 63(24):8600-5. PubMed ID: 14695170
[TBL] [Abstract][Full Text] [Related]
37. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
Agrosi M; Mischiatti S; Harrasser PC; Savio D
Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
[TBL] [Abstract][Full Text] [Related]
38. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
Chen WT; Chen YK; Lin SS; Hsu FT
Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
[TBL] [Abstract][Full Text] [Related]
39. The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil.
Gariboldi MB; Taiana E; Bonzi MC; Craparotta I; Giovannardi S; Mancini M; Monti E
Cancer Lett; 2015 Aug; 364(2):156-64. PubMed ID: 25979228
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous determination of hypericin and hyperforin in human plasma and serum using liquid-liquid extraction, high-performance liquid chromatography and liquid chromatography-tandem mass spectrometry.
Pirker R; Huck CW; Bonn GK
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):147-53. PubMed ID: 12270208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
